Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF

Journal of Immunology

Volumn 166, Issue 6, 2001, Pages 4012-4019

  Wilhelm, P ^a   Ritter, U ^a   Labbow, S ^a   Donhauser, N ^a   Rollinghoff M ^a   Bogdan, C ^a   Korner H ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHIMERA; DELAYED HYPERSENSITIVITY; DISEASE COURSE; GENE DELETION; LEISHMANIASIS; MACROPHAGE; MOUSE; NONHUMAN; PARASITE CONTROL; PARASITOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL;

EID: 0035869456     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.6.4012     Document Type: Article

References (31)

1. The regulation of immunity to Leishmania major
2. The host response to Leishmania infection
3. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis
4. Type 1 interferon (IFN-α/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite
5. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-γ-stimulated macrophages by induction of tumor necrosis factor-α
6. Tumor necrosis factor-α in combination with interferon-γ, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes
7. Tumor necrosis factor-α synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide
8. Role of tumor necrosis factor in macrophage leishmanicidal activity in vitro and resistance to cutaneous leishmaniasis in vivo
9. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthese
10. Tumor necrosis factor plays a protective role in experimental routine cutaneous leishmaniasis
11. Tumour necrosis factor (TNFα) in leishmaniasis. I. TNFα mediates host protection against cutaneous leishmaniasis
12. Tumor necrosis factor α (TNF-α) and TNF-β and their receptors in experimental cutaneous leishmaniasis
13. Transgenic mice expressing high levels of soluble TNF-RI fusion protein are protected from lethal septic shock and cerebral malaria, and are highly susceptible to Listeria monocytogenes and Leishmania major
14. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication
15. Control of Leishmania major infection in mice lacking TNF-receptors
16. TNF receptor p55 is required for elimination of inflammatory cells following control of intracellular pathogens
17. Distinct roles for lymphotoxin-α and tumour necrosis factor in lymphoid tissue organogenesis and spatial organisation defined in gene targeted C57BL/6 Mice
18. Challenging cytokine redundancy: Inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis arc normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient mice
19. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice
20. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major
21. Cytokines in leishmaniasis: A complex network of stimulatory and inhibitory interactions
22. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity
23. Adenovirus-induced liver pathology is mediated through TNF receptors I and II but is independent of TNF or lymphotoxin
24. Immune and inflammatory responses in TNF-α-deficient mice: A critical requirement for TNF-α in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response
25. Structural deficiencies in granuloma formation in tumor necrosis factor-gene targeted mice underlie a heightened sensitivity to aerosol Mycobacterium tuberculosis infection
26. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection
27. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice
28. Lymphotoxin α/β and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T celt areas of the spleen
29. Tumor necrosis factor: A master-regulator of leukocyte movement
30. Generation of splenic follicular structure and B cell movement in tumor necrosis factor-deficient mice
31. The role of nitric oxide in innate immunity